.png&w=384&q=75)
This solution is indicated as a source of water, electrolytes and calories or as an alkalinizing agent.
This is a sterile, nonpyrogenic solution for fluid and electrolyte replenishment and caloric supply in a single dose container for intravenous administration.
As directed by a physician. Dosage is dependent upon the age, weight and clinical condition of the patient as well as laboratory determinations. The dosage and constant infusion rate of intravenous dextrose must be selected with caution in pediatric patients, particularly neonates and low weight infants, because of the increased risk of hyperglycemia/ hypoglycemia. Additives may be incompatible. Administration Procedure:
There are no known drug interactions and none well documented.
Solutions containing dextrose may be contraindicated in patients with known allergy to corn or corn products.
Allergic reactions or anaphylactoid symptoms such as localized or generalized urticaria and pruritus; periorbital, facial, and/or laryngeal edema, coughing, sneezing, and/or difficulty with breathing have been reported during administration. The reporting frequency of these signs and symptoms is higher in women during pregnancy.
Teratogenic effect and pregnancy category C. This solution should be given to a pregnant woman only if clearly needed. It is not known whether this drug is excreted in human milk.
Should be stored at controlled room temperature.
Each 100 ml contains-